Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    December 2018
  1. SCHUSTER SJ, Bishop MR, Tam CS, Waller EK, et al
    Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2018 Dec 1. doi: 10.1056/NEJMoa1804980.
    PubMed     Text format     Abstract available


    November 2018
  2. ADVANI R, Flinn I, Popplewell L, Forero A, et al
    CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
    N Engl J Med. 2018;379:1711-1721.
    PubMed     Text format     Abstract available


    October 2018
  3. ALZAHRANI MF, AlJasser MI
    Nail Changes during Chemotherapy.
    N Engl J Med. 2018;379:1561.
    PubMed     Text format    


  4. BACH PB
    National Coverage Analysis of CAR-T Therapies - Policy, Evidence, and Payment.
    N Engl J Med. 2018;379:1396-1398.
    PubMed     Text format    


    September 2018
  5. MORSCHHAUSER F, Fowler NH, Feugier P, Bouabdallah R, et al
    Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
    N Engl J Med. 2018;379:934-947.
    PubMed     Text format     Abstract available


  6. HANDY MARSHALL C, Nahas-Vigon J, Manesh R, Gelber AC, et al
    Just Beneath the Surface.
    N Engl J Med. 2018;379:968-973.
    PubMed     Text format    


  7. TIACCI E, Venanzi A, Ascani S, Marra A, et al
    High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML.
    N Engl J Med. 2018;379:981-984.
    PubMed     Text format    


    August 2018
  8. KATAOKA K, Ogawa S
    PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma.
    N Engl J Med. 2018;379:696.
    PubMed     Text format    


  9. ISHITSUKA K, Utsunomiya A, Ishida T
    PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma.
    N Engl J Med. 2018;379:695.
    PubMed     Text format    



  10. PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma.
    N Engl J Med. 2018;379:695-697.
    PubMed     Text format    


  11. SHAH NN, Singavi AK, Harrington A
    Daratumumab in Primary Effusion Lymphoma.
    N Engl J Med. 2018;379:689-690.
    PubMed     Text format    



  12. Genetics of Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2018;379:493-494.
    PubMed     Text format    


  13. NARESH KN
    Genetics of Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2018;379:493.
    PubMed     Text format    


  14. CUMMIN TE, Du MQ, Johnson P
    Genetics of Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2018;379:493.
    PubMed     Text format    


    May 2018
  15. RATNER L, Waldmann TA, Janakiram M, Brammer JE, et al
    Rapid Progression of Adult T-Cell Leukemia-Lymphoma after PD-1 Inhibitor Therapy.
    N Engl J Med. 2018;378:1947-1948.
    PubMed     Text format    


    April 2018
  16. BORCHARD NA, Nayak JV
    Orbital Apex Syndrome.
    N Engl J Med. 2018;378:e23.
    PubMed     Text format    


  17. CANELLOS GP, LaCasce AS
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1560.
    PubMed     Text format    


  18. CRUMP M
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1559-60.
    PubMed     Text format    


  19. GREER JP
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1559.
    PubMed     Text format    


  20. HILAL T
    Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1558-9.
    PubMed     Text format    



  21. Brentuximab Vedotin for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:1558-1561.
    PubMed     Text format    


  22. SCHMITZ R, Wright GW, Huang DW, Johnson CA, et al
    Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2018;378:1396-1407.
    PubMed     Text format     Abstract available


    March 2018
  23. TAM CS, Anderson MA, Pott C, Agarwal R, et al
    Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.
    N Engl J Med. 2018;378:1211-1223.
    PubMed     Text format     Abstract available


  24. ARD KL, Kelly HR, Gandhi RT, Louissaint A Jr., et al
    Case 9-2018: A 55-Year-Old Man with HIV Infection and a Mass on the Right Side of the Face.
    N Engl J Med. 2018;378:1143-1152.
    PubMed     Text format    


  25. QUINTAS-CARDAMA A
    CAR T-Cell Therapy in Large B-Cell Lymphoma.
    N Engl J Med. 2018;378:1065.
    PubMed     Text format    



  26. CAR T-Cell Therapy in Large B-Cell Lymphoma.
    N Engl J Med. 2018;378:1065.
    PubMed     Text format    


  27. YARCHOAN R, Uldrick TS
    HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:1029-1041.
    PubMed     Text format    



  28. Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2018;378:878.
    PubMed     Text format    


    December 2017
  29. NAIR R, Tabchi S, Hagemeister F
    Obinutuzumab Treatment of Follicular Lymphoma.
    N Engl J Med. 2017;377:2605.
    PubMed     Text format    



  30. Obinutuzumab Treatment of Follicular Lymphoma.
    N Engl J Med. 2017;377:2605-2606.
    PubMed     Text format    


  31. SCHUSTER SJ, Svoboda J, Chong EA, Nasta SD, et al
    Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.
    N Engl J Med. 2017;377:2545-2554.
    PubMed     Text format     Abstract available


  32. NEELAPU SS, Locke FL, Bartlett NL, Lekakis LJ, et al
    Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
    N Engl J Med. 2017 Dec 10. doi: 10.1056/NEJMoa1707447.
    PubMed     Text format     Abstract available


  33. LONGO DL, DeVita VT Jr
    Progress in the Treatment of Hodgkin's Lymphoma.
    N Engl J Med. 2017 Dec 10. doi: 10.1056/NEJMe1715141.
    PubMed     Text format    


  34. CONNORS JM, Jurczak W, Straus DJ, Ansell SM, et al
    Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
    N Engl J Med. 2017 Dec 10. doi: 10.1056/NEJMoa1708984.
    PubMed     Text format     Abstract available


    November 2017

  35. More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.
    N Engl J Med. 2017;377:2101-2102.
    PubMed     Text format    


  36. TIBERGHIEN P, Deconinck E, Adotevi O
    More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.
    N Engl J Med. 2017;377:2101-2.
    PubMed     Text format    


    October 2017
  37. MARCUS R, Davies A, Ando K, Klapper W, et al
    Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.
    N Engl J Med. 2017;377:1331-1344.
    PubMed     Text format     Abstract available


  38. ARMITAGE JO, Longo DL
    Which Anti-CD20 Antibody Is Better in Follicular Lymphoma?
    N Engl J Med. 2017;377:1389-1390.
    PubMed     Text format    


    September 2017
  39. LE GOUILL S, Thieblemont C, Oberic L, Moreau A, et al
    Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
    N Engl J Med. 2017;377:1250-1260.
    PubMed     Text format     Abstract available


  40. RUSH RP, Saltman AP, Prica AA, Breiner A, et al
    Connecting the Dots.
    N Engl J Med. 2017;377:978-984.
    PubMed     Text format    


    August 2017
  41. ABRAMSON JS, McGree B, Noyes S, Plummer S, et al
    Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.
    N Engl J Med. 2017;377:783-784.
    PubMed     Text format    


  42. LACASCE AS, Flores EJ, Goldstein RH, Sohani AR, et al
    Case 25-2017.
    N Engl J Med. 2017;377:677-688.
    PubMed     Text format    


    July 2017
  43. MELANI C, Major A, Schowinsky J, Roschewski M, et al
    PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.
    N Engl J Med. 2017;377:89-91.
    PubMed     Text format    


    June 2017
  44. DAVID WS, Bowley MP, Mehan WA Jr, Shin JH, et al
    Case 19-2017 - A 53-Year-Old Woman with Leg Numbness and Weakness.
    N Engl J Med. 2017;376:2471-2481.
    PubMed     Text format    


    April 2017
  45. HOCHBERG EP, Bierer MF, Winkfield KM, Chen YB, et al
    Case 11-2017 - A 61-Year-Old Woman with Leg Swelling, Back Pain, and Hydronephrosis.
    N Engl J Med. 2017;376:1461-1471.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: